Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 3
1994 8
1995 8
1996 17
1997 22
1998 32
1999 30
2000 36
2001 42
2002 48
2003 28
2004 28
2005 43
2006 31
2007 34
2008 40
2009 44
2010 43
2011 55
2012 57
2013 76
2014 78
2015 80
2016 97
2017 91
2018 108
2019 97
2020 63
Text availability
Article attribute
Article type
Publication date

Search Results

1,213 results
Results by year
Filters applied: . Clear all
Page 1
α4β7 integrin inhibitors: a patent review.
Li H, Huang SY, Shi FH, Gu ZC, Zhang SG, Wei JF. Li H, et al. Expert Opin Ther Pat. 2018 Dec;28(12):903-917. doi: 10.1080/13543776.2018.1549227. Epub 2018 Nov 22. Expert Opin Ther Pat. 2018. PMID: 30444683 Review.
Vedolizumab.
[No authors listed] [No authors listed] 2020 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012–. PMID: 31644050 Free Books & Documents. Review.
The safety of vedolizumab for the treatment of ulcerative colitis.
Novak G, Hindryckx P, Khanna R, Jairath V, Feagan BG. Novak G, et al. Expert Opin Drug Saf. 2017 Apr;16(4):501-507. doi: 10.1080/14740338.2017.1300251. Epub 2017 Mar 5. Expert Opin Drug Saf. 2017. PMID: 28276855 Review.
Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease.
Lamb CA, O'Byrne S, Keir ME, Butcher EC. Lamb CA, et al. J Crohns Colitis. 2018 Aug 22;12(suppl_2):S653-S668. doi: 10.1093/ecco-jcc/jjy060. J Crohns Colitis. 2018. PMID: 29767705 Review.
New biologics and small molecules in inflammatory bowel disease: an update.
Sabino J, Verstockt B, Vermeire S, Ferrante M. Sabino J, et al. Therap Adv Gastroenterol. 2019 May 26;12:1756284819853208. doi: 10.1177/1756284819853208. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31205488 Free PMC article. Review.
The Role of Integrin α4β7 in HIV Pathogenesis and Treatment.
Arthos J, Cicala C, Nawaz F, Byrareddy SN, Villinger F, Santangelo PJ, Ansari AA, Fauci AS. Arthos J, et al. Curr HIV/AIDS Rep. 2018 Apr;15(2):127-135. doi: 10.1007/s11904-018-0382-3. Curr HIV/AIDS Rep. 2018. PMID: 29478152 Free PMC article. Review.
Vedolizumab in the treatment of Crohn's disease.
Tarabar D, Hirsch A, Rubin DT. Tarabar D, et al. Expert Rev Gastroenterol Hepatol. 2016;10(3):283-90. doi: 10.1586/17474124.2016.1135051. Epub 2016 Jan 25. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26810276 Review.
Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis.
Duc D, Vigne S, Bernier-Latmani J, Yersin Y, Ruiz F, Gaïa N, Leo S, Lazarevic V, Schrenzel J, Petrova TV, Pot C. Duc D, et al. Cell Rep. 2019 Oct 8;29(2):378-390.e4. doi: 10.1016/j.celrep.2019.09.002. Cell Rep. 2019. PMID: 31597098 Free article.
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab.
Wyant T, Fedyk E, Abhyankar B. Wyant T, et al. J Crohns Colitis. 2016 Dec;10(12):1437-1444. doi: 10.1093/ecco-jcc/jjw092. Epub 2016 Jun 1. J Crohns Colitis. 2016. PMID: 27252400 Review.
MAdCAM costimulation through Integrin-α4β7 promotes HIV replication.
Nawaz F, Goes LR, Ray JC, Olowojesiku R, Sajani A, Ansari AA, Perrone I, Hiatt J, Van Ryk D, Wei D, Waliszewski M, Soares MA, Jelicic K, Connors M, Migueles SA, Martinelli E, Villinger F, Cicala C, Fauci AS, Arthos J. Nawaz F, et al. Mucosal Immunol. 2018 Sep;11(5):1342-1351. doi: 10.1038/s41385-018-0044-1. Epub 2018 Jun 6. Mucosal Immunol. 2018. PMID: 29875402 Free PMC article.
1,213 results
Jump to page
Feedback